Expression of tissue type plasminogen activator and type 1 plasminogen activator inhibitor, and persistent fibrin deposition in chronic renal allograft failure

Kidney International

Volumn 52, Issue 2, 1997, Pages 371-377

  Wang, Yiming ^a   Pratt, Julian R ^b   Hartley, Barrie ^b   Evans, Beryl ^b   Zhang, Lyna ^b   Sacks, Steven H ^b  

^a GUY S HOSPITAL   (United Kingdom)

^b NONE

Author keywords

Allograft failure; Fibrin; Plasminogen activator inhibitor; Tissue type plasminogen activator; Transplantation

Indexed keywords

FIBRIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; FIBRIN DEPOSITION; IMMUNOHISTOCHEMISTRY; KIDNEY ALLOGRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; NONHUMAN; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

EID: 0030850907     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1997.343     Document Type: Article

References (32)

1. TILNEY NL, WHITLEY WD, DIAMOND JR, KUPIEC-WEGLINSKI JW, ADAMS DH: Chronic rejection-An undefined conundrum. Transplantation 52:384-396, 1991
2. PORTER KA: Renal Transplantation: Pathology of the Kidney. Boston, Toronto and London, Little Brown and Co, 1982, pp 1799-1934
3. KINCAID-SMITH P: Histological diagnosis of rejection of renal homografts in man. Lancet 2:849-852, 1967
4. STEIN-OAKLEY AN, JABLONSKI P, TZANIDIS A, BAXTER K, HOWDEN BO, MARSHALL VC, THOMSON NM: Development of chronic injury and nature of interstitial infiltrate in a model of chronic renal allograft rejection. Transplantation 56:1299-1305, 1993
5. TILNEY NL, WHITLEY WD, TULLIUS SG, HEEMANN UW, WASOWSKA B, BALDWIN III WM, HANCOCK WW: Serial analysis of cytokines, adhesion molecule expression, and humoral responses during development of chronic kidney allograft rejection in a new rat model. Transplant Proc 25:861-862, 1993
6. TULLIUS SG, HANCOCK WW, HEEMANN U, AZUMA H, TILNEY NL: Reversibility of chronic renal allograft rejection. Transplantation 58:93-99, 1994
7. BUKOVSKY A, LABARRERE CA, HAAG B, CARTER C, FAULK WP: Tissue factor in normal and transplanted human kidneys. Transplantation 54:644-650, 1992
8. FAULK WP, LABARRERE CA: Vascular immunopathology and atheroma development in human allografted organs. Arch Pathol Lab Med 116:1337-1344, 1992
9. ABSHER E, LABARRERE CA, CARTER C, HAAG B, FAULK WP: The endothelial heparan sulfate-antithrombin III natural anticoagulant pathway in normal and transplanted human kidneys. Transplantation 53:828-834, 1992
10. BERGSTEIN JM: Glomerular fibrin deposition and removal. Pediatr Nephrol 4:78-87, 1990
11. KWAAN HC: The role of fibrinolysis in disease processes. Semin Thromb Hemost 10:71-79, 1984
12. SRAER JD, KANFER A, RONDEAU E, LACAVE R: Glomerular hemostasis in normal and pathological conditions. Adv Nephrol 17:27-56, 1988
13. FAULK WP, GARGIULO P, MCINTYRE JA, BANG NU: Hemostasis and fibrinolysis in renal transplantion. Semin Thromb Hemost 15:88-98, 1989
14. WANG Y, THOMPSON EM, WHAWELL SA, FLEMING KA: Expression and localisation of plasminogen activator inhibitor 1 mRNA in transplant kidneys. J Pathol 169:445-450, 1993
15. TANABE K, TOMA H, SAGARA R, TAKAHASHI K, TERAOKA S, OTA K: Experimental model of chronic renal allograft rejection in rats and therapeutic efficacy of a new selective thromboxane A2 (TXA2) synthetase inhibitor (CV-4151). Transplant Proc 21:293-295, 1989
16. CHOMCZYNSKI P, SACCHI N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-choloroform extraction. Anal Biochem 162:156-159, 1987
17. NY T, LEONARDSSON G, HSUEH AJW: Cloning and characterization of a cDNA for rat tissue-type plasminogen activator. DNA 7:671-677, 1988
18. ZEHEB R, GELEHRTER TD: Cloning and sequencing of cDNA for rat plasminogen activator inhibitor-1. Gene 73:459-468, 1988
19. AUSUBEL FM, BRENT R, KINGSTON RE, MOORE DD, SEIDMAN JG, SMITH JA, STRUHL K, ALBRIGHT LM, COEN DM, VARKI A, JANSSEN K: Preperation and Analysis of RNA: Current Protocols in Molecular Biology. New York, John Wiley and Sons, 1995
20. SUMI Y, DENT MA, OWEN DE, SEELEY PJ, MORRIS RJ: The expression of tissue and urokinase-type plasminogen activators in neural development suggests different models of proteolytic involvement in neuronal growth. Development 116:625-637, 1992
21. HSU SM, RAINE L, FANGER H: Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29:577-580, 1981
22. LARSSON A, ASTEDT B: Immunohistochemical localisation of tissue plasminogen activator and urokinase in the vessel wall. J Clin Pathol 38:140-145, 1985
23. HUI KY, HABER E, MATSUEDA GR: Monoclonal antibodies to a synthetic fibrin-like peptide bind to human fibrin but not fibrinogen. Science 222:1129-1131, 1983
24. WANG Y, PRATT JR, TAM FWK, HARTLEY RB, WOLFF JA, OLAVESEN MG, SACKS SH: Up-regulation of type 1 plasminogen activator inhibitor (PAI-1) mRNA with thrombotic changes in renal grafts. Transplantation 61:684-689, 1996
25. LEVI M, WILMINK J, BULLER HR, SURACHNO J, TEN CATE JW: Impaired fibrinolysis in cyclosporine-treated renal transplant patients: Analysis of the defect and beneficial effect of fish-oil. Transplantation 54:978-983, 1992
26. THALACKER FW, NILSEN-HAMILTON M: Opposite and independent actions of cyclic AMP and transforming growth factor beta in the regulation of type 1 plasminogen activator inhibitor expression. Biochem J 287:855-862, 1992
27. WOJTA J, NAKAMURA T, FABRY A, HUFNAGL P, BECKMANN R, MCGRATH K, BINDER BR: Hepatocyte growth factor stimulates expression of plasminogen activator inhibitor type 1 and tissue factor in HepG2 cells. Blood 84:151-157, 1994
28. CAMPBELL IK, LAST K, NOVAK U, LUND LR, HAMILTON JA: Recombinant human interleukin 1 inhibits plasminogen activator inhibitor 1 (PAI-1) production by human articular cartilage and chondrocytes. Biochem Biophys Res Commun 174:251-257, 1991
29. CAMPBELL IK, WOJTA J, NOVAK U, HAMILTON JA: Cytokine modulation of plasminogen activator inhibitor 1 (PAI-1) production by human articular cartilage and chondrocytes. Down-regulation by tumor necrosis factor alpha and up-regulation by transforming growth factor beta, basic fibroblast growth factor. Biochim Biophys Acta 1226:277-285, 1994
30. SAWDEY MS, LOSKUTOFF DJ: Regulation of murine type 1 plasminogen activator inhibitor gene expression in vivo. Tissue specificity and induction by lipopolysaccharide, tumor necrosis factor-alpha, and transforming growth factor-beta. J Clin Invest 88:1346-1353, 1991
31. TOMOSUGI N, WADA T, NAITO T, TAKASAWA K, YOKOYAMA H, KIDA H, KOBAYASHI K: Role of plasminogen activator inhibitor on nephrotoxic nephritis and its modulation by tumor necrosis factor. Nephron 62:213-219, 1992
32. MANNON RB, SUNDAR SK, SANFILIPPO FP, COFFMAN TM: Alterations in renal interleukin-1 production during kidney transplant rejection in the rat. The effects of high-dose methylprednisolone. Transplantation 56:1157-1162, 1993